Flow Cytometric Examination Reveals Vimentin and CD44 Are Co-expressed with CD133 in a Small Subpopulation for all three of the Metastasis-Derived Prostate Cancer Cell Lines. The gene discussed is VIM; the disease is prostate cancer.